Q-omics provides the consensus-scored TAAR3P profile across patient tissues and cancer cell-line models. TAAR3P expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, TAAR3P is differentially expressed in 10, with the highest sampling consensus in KICH. Additionally, TAAR3P RNA expression shows 9,391 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight KIRP, KICH, and ESCA as cancer lineages where TAAR3P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TAAR3P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TAAR3P survival associations across molecular data types. TAAR3P RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TAAR3P RNA expression–survival associations across cancer types. High TAAR3P expression shows unfavorable associations in KIRP, BRCA, ACC and UCEC, but favorable associations in SKCM and BLCA. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for TAAR3P RNA expression.
This table summarizes TAAR3P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for TAAR3P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TAAR3P shows lower tumor expression in KICH and KIRP and higher tumor expression in ESCA, STAD, READ and COAD. The KICH box plot shows higher TAAR3P RNA expression in normal versus tumor tissue (log2 FC = −0.056, t-test p < 0.001).
This table shows molecular features associated with TAAR3P in patient tissues and cancer cell lines. In patient samples, TAAR3P shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set. In cancer cell lines, TAAR3P RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.
